Oritavancin(LY-333328) |
Catalog No.GP10160 |
Oritavancin(LY-333328) (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 171099-57-3
Sample solution is provided at 25 µL, 10mM.
Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.
Average Rating: 5
(Based on Reviews and 15 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *